The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemia
Abstract
Interleukin‐10 (IL‐10) is a potent inhibitor of lipopolysaccharide (LPS)‐induced tumor necrosis factor (TNF) production and has been shown to protect mice from endotoxin shock. As IFN‐γ is another important mediator of LPS toxicity, we studied the effects of IL‐10 on LPS‐induced IFN‐γ synthesis in vitro and in vivo. First, we found that the addition of recombinant human IL‐10 (rhIL‐10) (10 U/ml) to human whole blood markedly suppressed LPS‐induced IFN‐γ release while neutralization of endogenously synthesized IL‐10 resulted in increased IFN‐γ levels. The ability of rIL‐10 to inhibit LPS‐induced IFN‐γ synthesis was also observed in vivo in mice. Indeed, administration of 1000 U recombinant mouse IL‐10 (rmIL‐10) 30 min before and 3 h after challenge of BALB/c mice with 100 μg LPS resulted in a threefold decrease in peak IFN‐γ serum levels. We then examined the production and the role of IL‐10 during murine endotoxemia. We found that LPS injection causes the rapid release of IL‐10, peak IL‐10 serum levels being observed 90 min after LPS challenge. Neutralization of endogenously produced IL‐10 by administration of 2 mg JES5‐2A5 anti‐IL‐10 monoclonal antibody (mAb) 2h before LPS challenge resulted in a marked increase in both TNF and IFN‐γ serum levels while irrelevant isotype‐matched mAb had no effect. The enhanced production of inflammatory cytokines in anti‐IL‐10 mAb‐treated mice was associated with a 60% lethality after injection of 500 μg LPS, while all mice pretreated with control mAb survived. We conclude that the rapid release of IL‐10 during endotoxemia is a natural antiinflammatory response controlling cytokine production and LPS toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,385
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,243
Macrophage deactivation by interleukin 10.
Bogdan, C., Vodovotz, Y., & Nathan, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,238
Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospísil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C., & Trinchieri, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.869 · Cited by 961
Gérard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., & Velu, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.547 · Cited by 796
Self-citationInterleukin 10 protects mice from lethal endotoxemia.
Howard, M., Muchamuel, T., Andrade, S., & Menon, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1205 · Cited by 792
Tripp, C. S., Wolf, S. F., & Unanue, E. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3725 · Cited by 776
The role of IL-10 in crossregulation of TH1 and TH2 responses
Mosmann, T. R., & Moore, K. W. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80015-5 · Cited by 768
Glauser, M. P., Zanetti, G., Baumgartner, J.-D., & Cohen, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91452-z · Cited by 716
Mathison, J. C., Wolfson, E., & Ulevitch, R. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113540 · Cited by 591
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10
O'Garra, A., Stapleton, G., Dhar, V., Pearce, M., Schumacher, J., Rugo, H., Barbls, D., Stall, A., Cupp, J., Moore, K., et al. (1990) · International Immunology · doi:10.1093/intimm/2.9.821 · Cited by 344
Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha
Doherty, G. M., Lange, J. R., Langstein, H. N., Alexander, H. R., Buresh, C. M., & Norton, J. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.5.1666 · Cited by 300
Interferon gamma inhibits interleukin 10 production by monocytes.
Chomarat, P., Rissoan, M. C., Banchereau, J., & Miossec, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.523 · Cited by 287
The role of IFN-gamma in the pathology of experimental endotoxemia.
Heinzel, F. P. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.9.2920 · Cited by 255
Silva, A. T., Bayston, K. F., & Cohen, J. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.2.421 · Cited by 197
Durez, P., Abramowicz, D., Gerard, C. M., van Mechelen, M., Amraoui, Z., Dubois, C., Léo, O., Velu, T. J., & Goldman, M. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.551 · Cited by 119
Self-citationPradier, O., Gerard, C. M., Delvaux, A., Lybin, M., Abramowicz, D., Capel, P., Velu, T. J., & Goldman, M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231048 · Cited by 98
Self-citationRole of Interferon- in Experimental Gram-Negative Sepsis
Silva, A. T., & Cohen, J. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.2.331 · Cited by 89
Modified Immunological Status of Anti-IL-10 Treated Mice
Ishida, H., Hastings, R., Thompson-Snipes, L., & Howard, M. (1993) · Cellular Immunology · doi:10.1006/cimm.1993.1119 · Cited by 75
Jephthah-Ochola, J., Urmson, J. R., Farkas, S., & Halloran, P. F. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.792 · Cited by 57
Gonzalez, J. C., Johnson, D., Morrison, D. C., Freudenberg, M. A., Galanos, C., & Silverstein, R. (1993) · Infection and Immunity · doi:10.1128/iai.61.3.970-974.1993 · Cited by 30
A role for interleukin 1 in the in vivo actions of tumor necrosis factor.
Brouckaert, P., Libert, C., Everaerdt, B., Takahashi, N., & Fiers, W. (1989) · PubMed · Cited by 17
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Opal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
Fujihara, M., Muroi, M., Tanamoto, K.-I., Suzuki, T., Azuma, H., & Ikeda, H. (2003) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.08.003 · Cited by 574
Effect of interleukin‐10 on dendritic cell maturation and function
de Smedt, T., van Mechelen, M., De Becker, G., Urbain, J., Leo, O., & Moser, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270526 · Cited by 565
Metadata
- Authors
- Marchant, A., Bruyns, C., Vandenabeele, P., Ducarme, M., Gérard, C., Delvaux, A., De Groote, D., Abramowicz, D., Velu, T., & Goldman, M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1994-05
- Volume
- 24
- Issue
- 5
- Pages
- 1167-1171
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984296249
- Cited by
- 294
- References
- 26
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.